Excess mortality and morbidity in patients surviving infective endocarditis

American Heart Journal

Volumn 164, Issue 1, 2012, Pages 94-101

  Thuny, Franck ^a   Giorgi, Roch ^a   Habachi, Raja ^a   Ansaldi, Sebastien ^a   Le Dolley, Yvan ^a   Casalta, Jean Paul ^a   Avierinos, Jean François ^a   Riberi, Alberto ^a   Renard, Sebastien ^a   Collart, Frederic ^a   Raoult, Didier ^a   Habib, Gilbert ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AORTA VALVE DISEASE; ARTICLE; BACTERIAL ENDOCARDITIS; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; ENTEROCOCCAL INFECTION; FEMALE; FOLLOW UP; HAZARD RATIO; HEART VALVE SURGERY; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBSERVATIONAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT INFECTION; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; SURVIVAL PREDICTION; SURVIVAL RATE; TERTIARY HEALTH CARE; UNIVERSITY HOSPITAL;

COHORT STUDIES; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; SURVIVAL RATE;

EID: 84863719284     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.04.003     Document Type: Article

References (32)

1. Bashore TM, Cabell C, Fowler Jr V. Update on infective endocarditis. Curr Probl Cardiol 2006;31:274-352.
2. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005;111:e394-434.
3. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 2009;30:2369-413.
4. Hasbun R, Vikram HR, Barakat LA, et al. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA 2003;289:1933-40. (Pubitemid 37430224)
5. Thuny F, Di Salvo G, Belliard O, et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicentre study. Circulation 2005;112:69-75. (Pubitemid 40962571)
6. San Roman JA, Lopez J, Vilacosta I, et al. Prognostic stratification of patients with left-sided endocarditis determined at admission. Am J Med 2007;120:e361-7.
7. Chu VH, Cabell CH, Benjamin Jr DK, et al. Early predictors of inhospital death in infective endocarditis. Circulation 2004;109:1745-9. (Pubitemid 38500677)
8. Sy RW, Chawantanpipat C, Richmond DR, et al. Development and validation of a time-dependent risk model for predicting mortality in infective endocarditis. Eur Heart J 2011;32:2016-26.
9. Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009;169:463-73.
10. Tornos MP, Permanyer-Miralda G, Olona M, et al. Long-term complications of native valve infective endocarditis in non-addicts. A 15-year follow-up study. Ann Intern Med 1992;117:567-72.
11. Castillo JC, Anguita MP, Ramirez A, et al. Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study. Heart 2000;83:525-30. (Pubitemid 30316716)
12. Netzer RO, Altwegg SC, Zollinger E, et al. Infective endocarditis: determinants of long term outcome. Heart 2002;88:61-6. (Pubitemid 34665005)
13. Mansur AJ, Dal Bo CM, Fukushima JT, et al. Relapses, recurrences, valve replacements, and mortality during the long-term follow-up after infective endocarditis. Am Heart J 2001;141:78-86. (Pubitemid 32061315)
14. Martinez-Selles M, Munoz P, Estevez A, et al. Long-term outcome of infective endocarditis in non-intravenous drug users. Mayo Clin Proc 2008;83:1213-7.
15. Renzulli A, Carozza A, Romano G, et al. Recurrent infective endocarditis: a multivariate analysis of 21 years of experience. Ann Thorac Surg 2001;72:39-43. (Pubitemid 32643007)
16. Heiro M, Helenius H, Hurme S, et al. Long-term outcome of infective endocarditis: a study on patients surviving over one year after the initial episode treated in a Finnish teaching hospital during 25 years. BMC Infect Dis 2008;8:49.
17. Bolard P, Quantin C, Esteve J, et al. Modelling time-dependent hazard ratios in relative survival: application to colon cancer. J Clin Epidemiol 2001;54:986-96. (Pubitemid 32888365)
18. Giorgi R, Belot A, Gaudart J, et al. The performance of multiple imputation for missing covariate data within the context of regression relative survival analysis. Stat Med 2008;27:6310-31.
19. Hoen B, Alla F, Selton-Suty C, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002;288:75-81. (Pubitemid 34705521)
20. Remontet L, Bossard N, Belot A, et al. An overall strategy based on regression models to estimate relative survival and model the effects of prognostic factors in cancer survival studies. Stat Med 2007;26:2214-28. (Pubitemid 46680857)
21. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-8.
22. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83. (Pubitemid 17055592)
23. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982;38:933-42.
24. Dickman PW, Sloggett A, Hills M, et al. Regression models for relative survival. Stat Med 2004;23:51-64. (Pubitemid 38072106)
25. Giorgi R, Abrahamowicz M, Quantin C, et al. A relative survival regression model using B-spline functions to model non-proportional hazards. Stat Med 2003;22:2767-84. (Pubitemid 37038356)
26. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Csaki F, editors. 2nd International Symposium on Information Theory; 1973. p. 268-81. Budapest.
27. Bossard N, Velten M, Remontet L, et al. Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM). Eur J Cancer 2007;43:149-60. (Pubitemid 46054480)
28. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48:e1-148.
29. Castillo JC, Anguita MP, Delgado M, et al. Clinical characteristics and prognosis of infective endocarditis in women. Rev Esp Cardiol 2008;61:36-40. (Pubitemid 351573756)
30. Sambola A, Fernandez-Hidalgo N, Almirante B, et al. Sex differences in native-valve infective endocarditis in a single tertiary-care hospital. Am J Cardiol 2010;106:92-8.
31. Klodas E, Enriquez-Sarano M, Tajik AJ, et al. Surgery for aortic regurgitation in women. Contrasting indications and outcomes compared with men. Circulation 1996;94:2472-8. (Pubitemid 26403575)
32. Aksoy O, Meyer LT, Cabell CH, et al. Gender differences in infective endocarditis: pre- and co-morbid conditions lead to different management and outcomes in female patients. Scand J Infect Dis 2007;39:101-7. (Pubitemid 46277308)